Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
about
Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathwayThe expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT proteinViral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.Population levels of psychological stress, herpesvirus reactivation and HIV.Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.Molecular pathways in virus-induced cytokine production.Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction.Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virusCytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity.Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines.Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element.Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.
P2860
Q24657973-A4220E4E-E531-4086-A373-FAF68C90347EQ24680024-FDD929CD-9F1E-4C31-A018-3BF643441434Q33974199-6DA626C9-33AB-4C6C-9E7A-FB790C16F1B5Q34141187-6E9A673A-5BEC-4F09-98D7-B0F6CC47682DQ34174051-E6A6D529-4C0C-49D0-98E6-AC05706BA219Q34174972-84206FB4-BB75-41EA-9C72-AAC4C5A31DD3Q36380484-A40634FD-6489-4D2B-A3FA-63E13105C750Q36400897-7E0229E9-DE7C-4BB3-B6E5-CCA71A114E52Q36626966-C19FA14B-9848-4032-9288-9E11C57DCC2EQ36825115-0173D5BE-4743-454C-A3DC-3EDD1C040D48Q37385745-53F00F0F-BD89-41F9-A792-29EE46DD0937Q38356037-20C17711-1A83-4517-8B38-6579A0D5CCF6Q39606712-3FECEE54-B2E5-4697-BC83-C515F9C6229EQ40042560-33F34674-C6E6-4692-9343-54C1E36E3CB6Q40165254-788228D1-DAB4-4223-9F33-323308E46BA4Q52319664-A46EDA7A-4C46-42FD-915F-97CF93C0496B
P2860
Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Epstein-Barr virus nuclear ant ...... immunodeficiency virus type 1.
@en
type
label
Epstein-Barr virus nuclear ant ...... immunodeficiency virus type 1.
@en
prefLabel
Epstein-Barr virus nuclear ant ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus nuclear ant ...... immunodeficiency virus type 1
@en
P2093
Ambrosino C
Mallardo M
Squitieri B
P2860
P304
P407
P577
1993-05-01T00:00:00Z